Bio Spec

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Overview

Bio Spec Overview

Ignite Creation Date: 2025-12-24 @ 1:14 PM
Last Modification Date: 2025-12-24 @ 1:14 PM
Retention: SAMPLES_WITH_DNA
Description: EDTA-blood and urine sample for central laboratory analysis of agalsidase antibodies and Gb3 for safety issues.

There will be a proteomic analysis in blood to check whether there will be the possibility to characterize a biomarker for Fabry disease.
Section: EDTA-blood and urine sample for central laboratory analysis of agalsidase antibodies and Gb3 for safety issues. There will be a proteomic analysis in blood to check whether there will be the possibility to characterize a biomarker for Fabry disease.